by qfrsolutions | Jan 6, 2016 | News
Source: USA Today Valeant Pharmaceuticals International, the Canadian drugmaker whose CEO has been on medical leave while it faces congressional scrutiny over its pricing practices, said Wednesday it appointed Howard B. Schiller as interim CEO, effective immediately....
by qfrsolutions | Dec 15, 2015 | News
Source: The Wall Street Journal Valeant Pharmaceuticals International Inc. said Tuesday it has found a new partner to replace the controversial mail-order pharmacy that had helped patients fill prescriptions for the company’s pricey skin and other drugs....
by qfrsolutions | Dec 8, 2015 | News
Source: PR Newswire DECEMBER 08, 2015 Collaboration will deliver healthcare professionals and consumers enhanced value and access to leading facial and body aesthetic innovations. FORT WORTH, Texas & PLEASANTON, California, December 8, 2015 – Galderma, a global...
by qfrsolutions | Dec 1, 2015 | News
Source: South Korean electronics giant Samsung got into biologics production with the boast that its manufacturing expertise would allow it to produce products at half the cost of Western drugmakers. It is backing that up with plans for a new plant it says will make...
by qfrsolutions | Nov 23, 2015 | News
Source: USA Today U.S. pharmaceutical giant Pfizer(PFE) and Irish rival Allergan(AGN) Monday announced a record-breaking $160-billion merger, the largest in health-care industry history and the biggest yet using a controversial tax-saving strategy. In a transaction...
by qfrsolutions | Nov 12, 2015 | News
Source: A U.S. judge said Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) and activist hedge fund manager William Ackman must face a lawsuit accusing them of insider trading in Allergan Inc before making an unsuccessful takeover bid for the maker of Botox....
